BioMarCare is a cancer diagnostics company developing a cluster of high value tumor biomarkers for early detection, prognosis and monitoring of cancer and for companion diagnostics. The company's Multi-Biomarker Panel approach, combined with its technological and clinical expertise, promises to generate molecular and serum-based diagnostic blood tests with high specificity and sensitivity as well as rigorous validation. Our mission is to minimize uncertainty through early cancer detection and monitoring.
Looking for a particular BioMarCare Technologies employee's phone or email?
The BioMarCare Technologies annual revenue was $5.3 million in 2026.
1 people are employed at BioMarCare Technologies.
BioMarCare Technologies is based in Jerusalem, Jerusalem.
The NAICS codes for BioMarCare Technologies are [5417, 541, 54].
The SIC codes for BioMarCare Technologies are [28, 283].